Amgen Inc. (ETR:AMG)
277.35
+3.95 (1.44%)
Nov 7, 2025, 5:35 PM CET
Amgen Revenue
Amgen had revenue of $9.56B USD in the quarter ending September 30, 2025, with 12.40% growth. This brings the company's revenue in the last twelve months to $35.97B, up 10.56% year-over-year. In the year 2024, Amgen had annual revenue of $33.42B with 18.57% growth.
Revenue (ttm)
$35.97B
Revenue Growth
+10.56%
P/S Ratio
4.86
Revenue / Employee
$1.28M
Employees
28,000
Market Cap
148.90B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
| Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
| Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
| Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
| Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Amgen News
- 1 day ago - Amgen: Buy This Cheap Biotech Leader - Seeking Alpha
- 3 days ago - Stock Of The Day: Will Amgen Reverse Again? - Benzinga
- 3 days ago - Stock Of The Day: Will Amgen Reverse Again? - Benzinga
- 3 days ago - Amgen (AMGN) Receives Neutral Rating with Raised Price Target from Cantor Fitzgerald | AMGN ... - GuruFocus
- 3 days ago - AMGN Crosses Above Average Analyst Target - Nasdaq
- 3 days ago - Company News for Nov 6, 2025 - Nasdaq
- 3 days ago - Decoding Amgen Inc (AMGN): A Strategic SWOT Insight - GuruFocus
- 4 days ago - Amgen (AMGN) Shares Cross 3% Yield Mark - Nasdaq